Impact of Genomic Subtype on Intracranial Outcomes in Treatment-naive EGFR mutant NSCLC with Osimertinib (IGnITE).

已完结 10 由潘达发布于 2026/8/3 22:24:01

DOI:10.1016/j.jtho.2026.104114
作者：Emily Miao,?Emily Wo,?Lillian Boe,?James Lee,?Henry Walch,?Helena Yu,?Mitchell Parker,?Brandon Imber,?Jennifer Chiang,?Caressa Hui,?Nathaniel Myall,?Erqi Pollom,?Lisa Ni,?Steve Braunstein,?Christine H
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1016/j.jtho.2026.104114

Elsevier

Abstract：Introduction: Brain metastases (BM) causes significant morbidity and mortality in epidermal growth factor (EGFR) mutated non-small cell lung cancer (NSCLC). The effect of EGFR alteration sub

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:WileyRegulating interfacial stability of SiOx anode with fluoride-abundant solid–electrolyte interphase by fluorine-functionalized additive